Search Results 1771-1780 of 4117 for Solid
Measurable disease determined using guidelines of Response Evaluation Criteria In Solid Tumors (RECIST 1.1). Baseline tumor assessment should be performed ...
Mayo Clinic's pediatric solid tumor team met with pediatric patient Riley Kane's oncologist virtually and used 3D modeling to plan his surgery. Dr. Granberg ...
Willing and able to provide written informed consent for the trial; Measurable disease based on Response Evaluation Criteria in Solid Tumors (RECIST) 1.1; Had ...
Human immunodeficiency virus, hepatitis B virus, or hepatitis C virus positivity. History of solid organ transplantation; Known or suspected allergy or ...
... Solid Tumors (RECIST 1.1); For Part G, H, and I: Have measureable disease as defined by RECIST 1.1. For all Parts except Part F and H: Participants must have ...
History of prior allogeneic bone marrow progenitor cell or solid organ transplantation; Ongoing systemic immunosuppressive therapy other than corticosteroids ...
retrospective histopathological central review. - Presence of at least one measurable target lesion according to Response Evaluation Criteria In Solid Tumors ( ...
Solid organ transplantation. 4. Subject has current diagnosis/usage of: 1. BMI greater than or equal to 40.0 kg/m2 2. Human Immunodeficiency Virus (HIV) 3 ...
Recipient of previous non-renal solid organ and/or islet cell transplantation. Infection with HCV or HIV. Inability or unwillingness of a participant to ...
CT scans or MRIs must be assessed and documented on the Baseline Tumor Assessment Form (Response Evaluation Criteria in Solid Tumors [RECIST] 1.1). Must have ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!